COFCO Biotechnology Co., Ltd.
000930.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥20,053,355 | CN¥20,378,950 | CN¥19,918,051 | CN¥23,559,594 |
| % Growth | -1.6% | 2.3% | -15.5% | – |
| Cost of Goods Sold | CN¥18,907,634 | CN¥19,797,551 | CN¥17,837,425 | CN¥21,122,460 |
| Gross Profit | CN¥1,145,721 | CN¥581,399 | CN¥2,080,626 | CN¥2,437,133 |
| % Margin | 5.7% | 2.9% | 10.4% | 10.3% |
| R&D Expenses | CN¥128,828 | CN¥165,280 | CN¥132,863 | CN¥119,166 |
| G&A Expenses | CN¥629,123 | CN¥574,392 | CN¥603,952 | CN¥576,665 |
| SG&A Expenses | CN¥823,106 | CN¥780,902 | CN¥804,404 | CN¥799,739 |
| Sales & Mktg Exp. | CN¥193,983 | CN¥206,510 | CN¥200,453 | CN¥223,073 |
| Other Operating Expenses | CN¥122,276 | CN¥207,593 | -CN¥206,797 | CN¥143,406 |
| Operating Expenses | CN¥1,074,210 | CN¥1,153,775 | CN¥730,470 | CN¥1,062,311 |
| Operating Income | CN¥71,511 | -CN¥572,376 | CN¥1,350,156 | CN¥1,374,823 |
| % Margin | 0.4% | -2.8% | 6.8% | 5.8% |
| Other Income/Exp. Net | CN¥57,887 | CN¥29,836 | CN¥9,732 | CN¥2,564 |
| Pre-Tax Income | CN¥129,398 | -CN¥542,540 | CN¥1,359,888 | CN¥1,377,387 |
| Tax Expense | CN¥83,700 | CN¥73,752 | CN¥299,277 | CN¥247,876 |
| Net Income | CN¥25,130 | -CN¥601,630 | CN¥1,058,529 | CN¥1,129,603 |
| % Margin | 0.1% | -3% | 5.3% | 4.8% |
| EPS | 0.014 | -0.327 | 0.57 | 0.605 |
| % Growth | 104.1% | -157.3% | -5.8% | – |
| EPS Diluted | 0.014 | -0.327 | 0.57 | 0.605 |
| Weighted Avg Shares Out | 1,861,446 | 1,841,536 | 1,865,274 | 1,865,718 |
| Weighted Avg Shares Out Dil | 1,861,446 | 1,841,536 | 1,865,274 | 1,865,718 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥20,578 | CN¥11,079 | CN¥19,824 | CN¥15,448 |
| Interest Expense | CN¥108,309 | CN¥112,782 | CN¥90,782 | CN¥161,105 |
| Depreciation & Amortization | CN¥481,526 | CN¥466,841 | CN¥439,533 | CN¥434,939 |
| EBITDA | CN¥603,970 | CN¥47,105 | CN¥1,966,842 | CN¥2,119,254 |
| % Margin | 3% | 0.2% | 9.9% | 9% |